• Citer

Predicted effects of treatment for HCV infection vary among European countries.

par Deuffic-Burban, Sylvie;Deltenre, Pierre ;Buti, Maria;Stroffolini, Tommaso;Parkes, Julie;Mühlberger, Nikolai;Siebert, Uwe;Moreno, Christophe ;Hatzakis, Angelos;Rosenberg, William;Zeuzem, Stefan;Mathurin, Philippe
Référence Gastroenterology, 143, 4, page (974-85.e14)
Publication Publié, 2012-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Predicted effects of treatment for HCV infection vary among European countries.
Auteur:	Deuffic-Burban, Sylvie; Deltenre, Pierre; Buti, Maria; Stroffolini, Tommaso; Parkes, Julie; Mühlberger, Nikolai; Siebert, Uwe; Moreno, Christophe; Hatzakis, Angelos; Rosenberg, William; Zeuzem, Stefan; Mathurin, Philippe
Informations sur la publication:	Gastroenterology, 143, 4, page (974-85.e14)
Statut de publication:	Publié, 2012-10
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Direct-Acting Antiviral Agents
	Epidemiology Analysis
	Ribavirin
	Treatment Outcomes
MeSH keywords:	Aged
	Antiviral Agents -- therapeutic use
	Carcinoma, Hepatocellular -- epidemiology -- mortality -- virology
	Disease Progression
	Drug Therapy, Combination
	Europe -- epidemiology
	Female
	Hepacivirus -- genetics
	Hepatitis C, Chronic -- complications -- diagnosis -- drug therapy
	Humans
	Incidence
	Interferon-alpha -- therapeutic use
	Liver Cirrhosis -- epidemiology -- mortality -- virology
	Liver Neoplasms -- epidemiology -- mortality -- virology
	Male
	Markov Chains
	Mass Screening
	Middle Aged
	Polyethylene Glycols -- therapeutic use
	Protease Inhibitors -- therapeutic use
	Ribavirin -- therapeutic use
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0016-5085
	info:doi/10.1053/j.gastro.2012.05.054
	info:pii/S0016-5085(12)01151-1
	info:scp/84866672248
	info:pmid/22863764